↓ Skip to main content

A Novel Recombinant Vaccinia Virus Expressing the Human Norepinephrine Transporter Retains Oncolytic Potential and Facilitates Deep-Tissue Imaging

Overview of attention for article published in Molecular Medicine, May 2009
Altmetric Badge

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Novel Recombinant Vaccinia Virus Expressing the Human Norepinephrine Transporter Retains Oncolytic Potential and Facilitates Deep-Tissue Imaging
Published in
Molecular Medicine, May 2009
DOI 10.2119/molmed.2009.00014
Pubmed ID
Authors

Nanhai Chen, Qian Zhang, Yong A. Yu, Jochen Stritzker, Peter Brader, Andreas Schirbel, Samuel Samnick, Inna Serganova, Ronald Blasberg, Yuman Fong, Aladar A. Szalay

Abstract

Noninvasive and repetitive monitoring of a virus in target tissues and/or specific organs of the body is highly desirable for the development of safe and efficient cancer virotherapeutics. We have previously shown that the oncolytic vaccinia virus GLV-1h68 can target and eradicate human tumors in mice and that its therapeutic effects can be monitored by using optical imaging. Here, we report on the development of a derivative of GLV-1h68, a novel recombinant vaccinia virus (VACV) GLV-1h99, which was constructed to carry the human norepinephrine transporter gene (hNET) under the VACV synthetic early promoter placed at the F14.5L locus for deep-tissue imaging. The hNET protein was expressed at high levels on the membranes of cells infected with this virus. Expression of the hNET protein did not negatively affect virus replication, cytolytic activity in cell culture, or in vivo virotherpeutic efficacy. GLV-1h99-mediated expression of the hNET protein in infected cells resulted in specific uptake of the radiotracer [131I]-meta-iodobenzylguanidine (MIBG). In mice, GLV-1h99-infected tumors were readily imaged by [124I]-MIBG positron emission tomography. To our knowledge, GLV-1h99 is the first oncolytic virus expressing the hNET protein that can efficiently eliminate tumors and simultaneously allow deep-tissue imaging of infected tumors.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 3%
Unknown 29 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 20%
Student > Bachelor 5 17%
Researcher 5 17%
Student > Master 4 13%
Professor 2 7%
Other 0 0%
Unknown 8 27%
Readers by discipline Count As %
Agricultural and Biological Sciences 12 40%
Biochemistry, Genetics and Molecular Biology 3 10%
Medicine and Dentistry 3 10%
Psychology 1 3%
Engineering 1 3%
Other 0 0%
Unknown 10 33%